Status:
UNKNOWN
Continuous Versus Cyclic Oral Contraceptives for Endometriosis
Lead Sponsor:
University of Athens
Conditions:
Dysmenorrhea
Pelvic Pain
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
To evaluate the efficacy of oral contraceptives in a continuous fashion versus the usual cyclic fashion in the recurrence of endometriosis related symptoms and endometriomas following fertility-sparin...
Detailed Description
Oral contraceptives containing 0.03 mg ethinyl estradiol and 3mg drospirenone will be administered. One tablet a day for 21 days followed by 7 days pill free (cyclic fashion) or one tablet a day in a ...
Eligibility Criteria
Inclusion
- Women of reproductive age with Symptomatic endometriosis following fertility sparing surgery
Exclusion
- Contraindications of use of oral contraceptives
Key Trial Info
Start Date :
April 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02237131
Start Date
April 1 2014
End Date
December 1 2015
Last Update
September 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aretaieion Hospital
Athens, Athens, Greece